Interactions between human osteoblasts and prostate cancer cells in a novel 3D in vitro model

Organogenesis

Volumn 6, Issue 3, 2010, Pages 181-188

  Sieh, Shirly ^a   Lubik, Amy A ^a,b   Clements, Judith A ^a,b   Nelson, Colleen C ^a,b   Hutmacher, Dietmar W ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b Translational Research Institute   (Australia)

Author keywords

3D in vitro model; Bone metastasis; Co culture; Osteoblasts; Prostate cancer; Tissue engineering

Indexed keywords

BIOLOGICAL MARKER; CALCIUM PHOSPHATE; MATRIX METALLOPROTEINASE; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BONE MATRIX; BONE METASTASIS; CANCER CELL; CANCER CELL CULTURE; CELL INTERACTION; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; OSTEOBLAST; PROSTATE CANCER; TISSUE ENGINEERING;

CELL COMMUNICATION; CELL LINE, TUMOR; COCULTURE TECHNIQUES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION PROFILING; HUMANS; MALE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; OSTEOBLASTS; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 77956412826     PISSN: 15476278     EISSN: 15558592     Source Type: Journal    
DOI: 10.4161/org.6.3.12041     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer Statistics 2008; 2008:71-96.
2. Society CC. Canadian Cancer Statistics. 2009.
3. SEER. Fast facts: Prostate cancer: Survival and stage. National Cancer Institute 2008.
4. SWPHO. Prostate cancer survival by stage: South West Public Health Observatory 2008.
5. Sikes RA, Nicholson BE, Koeneman KS, Edlund NM, Bissonette EA, Bradley MJ, et al. Cellular interactions in the tropism of prostate cancer to bone 2004; 110:497-503.
6. Wiesner C, Bonfil RD, Dong Z, Yamamoto H, Nabha SM, Meng H, et al. Heterogeneous Activation of MMP-9 Due to Prostate Cancer-Bone Interaction. Urology 2007; 69:795-9.
7. Dai J, Hall CL, Escara-Wilke J, Mizokami A, Keller JM, Keller ET. Prostate cancer induces bone metastasis through wnt-induced bone morphogenetic protein-dependent and independent mechanisms. Cancer Res 2008; 68:5785-94.
8. Dong Z, Saliganan AD, Meng H, Nabha SM, Sabbota AL, Sheng S, et al. Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover. Neoplasia (New York, NY) 2008; 10:439-49.
9. Birgersdotter A, Sandberg R, Ernberg I. Gene expression perturbation in vitro-A growing case for three-dimensional (3D) culture systems. Seminars in Cancer Biology 2005; 15:405-12.
10. Weigelt B, Bissell MJ. Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Seminars in Cancer Biology 2008; 18:311-21.
11. Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge JS, Polverini PJ, et al. Engineering tumors with 3D scaffolds. Nat Meth 2007; 4:855-60.
12. Chu JH, Yu S, Hayward SW, Chan FL. Development of a three-dimensional culture model of prostatic epithelial cells and its use for the study of epithelialmesenchymal transition and inhibition of PI3K pathway in prostate cancer. The Prostate 2008; 69:428-42.
13. Fischbach C, Kong HJ, Hsiong SX, Evangelista MB, Yuen W, Mooney DJ. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement 2009; 399-404.
14. Zhou Y, Hutmacher DW, Varawan SL, Meng LT. Comparison of Human alveolar osteoblasts cultured on polymer-ceramic composite scaffolds and tissue culture plates. International Journal of Oral and Maxillofacial Surgery 2007; 36:137-45.
15. Zhou Y, Chen F, Ho ST, Woodruff MA, Lim TM, Hutmacher DW. Combined marrow stromal cell-sheet techniques and high-strength biodegradable composite scaffolds for engineered functional bone grafts. Biomaterials 2007; 28:814-24.
16. Nemeth JA, Yousif R, Herzog M, Che M, Upadhyay J, Shekarriz B, et al. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis 2002; 17-25.
17. Dong Z, Bonfil RD, Chinni S, Deng X, Trindade Filho JC, Bernardo M, et al. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue 2005; 1173-86.
18. Cao J, Chiarelli C, Richman O, Zarrabi K, Kozarekar P, Zucker S. Membrane type 1 matrix metalloproteinase induces epithelial-to-mesenchymal transition in prostate cancer 2008; 6232-40.
19. Nemeth JA, Harb JF, Barroso U Jr, He Z, Grignon DJ, Cher ML. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone 1999; 1987-93.
20. Yonou H, Yokose T, Kamijo T, Kanomata N, Hasebe T, Nagai K, et al. Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res 2001; 61:2177-82.
21. Schweikert HU, Rulf W, Niederle N, Schafer HE, Keck E, Kruck F. Testosterone metabolism in human bone 1980; 258-64.
22. Bruch HR, Wolf L, Budde R, Romalo G, Schweikert HU. Androstenedione metabolism in cultured human osteoblast-like cells 1992; 101-5.
23. Issa S, Schnabel D, Feix M, Wolf L, Schaefer H-E, Russell DW, et al. Human osteoblast-like cells express predominantly steroid 5{alpha}-reductase type 1. The Journal of Clinical Endocrinology & Metabolism 2002; 87:5401-7.
24. Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, Spellman PT, et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Molecular Oncology 2007; 1:84-96.
25. Dhurjati R, Krishnan V, Shuman L, Mastro A, Vogler E. Metastatic breast cancer cells colonize and degrade three-dimensional osteoblastic tissue in vitro. Clinical and Experimental Metastasis 2008; 25:741-52.
26. Marrero B, Messina J, Heller R. Generation of a tumor spheroid in a microgravity environment as a 3D model of melanoma. In Vitro Cellular & Developmental Biology - Animal 2009.
27. Nordstrand A, Nilsson J, Tieva Å, Wikström P, Lerner U, Widmark A. Establishment and validation of an in vitro co-culture model to study the interactions between bone and prostate cancer cells. Clinical and Experimental Metastasis 2009; 26:945-53.
28. Corey E, Quinn JE, Bladou F, Brown LG, Roudier MP, Brown JM, et al. Establishment and characterization of osseous prostate cancer models: Intra-tibial injection of human prostate cancer cells 2002; 52:20-33.
29. Webber M, Waghray A, Rhim J, Deocampo N. Urokinase and gelatinises in the proteolytic cascade in human prostate cancer invasion: Implication in cancer prevention. Proc Am Assoc Cancer Res 1995; 36:643.
30. Quax PHA, de Bart ACW, Schalken JA, Verheijen JH. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: Correlation with metastatic behavior in vivo 1997; 196-204.
31. Locke JA, Guns ES, Lubik AA, Adomat HH, Hendy SC, Wood CA, et al. Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer 2008; 6407-15.
32. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta]CT method. Methods 2001; 25:402-8.
33. Hutmacher DW. Biomaterials offer cancer research the third dimension. Nat Mater 2010; 9:90-3.